【6/4 12:00- 】Blockbuster TOKYO 2020 研修プログラム第1弾!「COVID-19の渦中で語り合う!創薬・医療系ベンチャーへのインパクト、過去からの学び」~Impact of COVID-19 on biotech startups, how to apply what we learned from the past~


-Blockbuster TOKYO 2020 第1回 研修プログラム!-

Seminar program in Blockbuster TOKYO 2020

Blockbuster TOKYOは東京都が主催、Beyond Next Ventures株式会社が運営をする創薬・医療系ベンチャー育成支援プログラムです。
Beyond Next Ventures, Inc. operates Tokyo Metropolitan Government's "Blockbuster TOKYO" which is an acceleration program for pharmaceutical and medical startup.


今回の研修セミナーでは、米国の生物学者・シリアルアントレプレナー・投資家であるUna Ryan氏に参画いただき、マクロな視点でディスカッションすることを想定しています。

また、セミナーの後半ではBlockbuster TOKYO 2019年度にご参加頂いた株式会社Elix CEO 結城 伸哉氏に登壇頂くとともに、Beyond Next Venturesより2020年度の活動紹介を行います。

The Covid19 pandemic has been called the "once in a century" black swan event. Hospital systems are overrun, global financial markets are crashing and the biotech industry is working day and night to develop rapid diagnostics, treatments and vaccines. This is unique time for bioventures; the entrepreneurs and management teams that can successfully navigate it will undoubtably be well rewarded. However, there is significant uncertainty in how the crisis will alter the ecosystem and shape the international bioeconomy in a post-Covid19 world. Never has there been a more important time to leverage the wisdom of others.

We would like to invite all of you to join us as Dr. Ryan provides her views on Corvid19, its impacts on the global biotech and bioventure ecosystem and how entrepreneurs and management teams can successfully navigate these challenges and capitalize on opportunities.

Also in the second half, we will invite Elix Inc. CEO Shinya Yuki to share his experience of participating Blockbuster TOKYO acceleration program 2019 year, and Beyond Next Ventures introduce Blockbuster TOKYO 2020.
We hope many people, such as who are interested in harmaceutical / medical startups in this seminar.



2020年6月4日(木) 12:00~13:30 (日本時間)
June 4, 2020 (Thu) 12: 00-13: 30 (JST)

【オンラインリンク/ Link for the online seminar】

【プログラム/ Contents】
  • 東京都及びBeyond Next Ventures からのご挨拶 / Introduction from Tokyo Metropolitan Government and Beyond Next Ventures
  • 『COVID-19の渦中で語り合う!創薬・医療系ベンチャーへのインパクト、過去からの学び/Impact of COVID-19 on biotech startups, how to apply what we learned from the past』 (Dr. Una Ryan)
  • ピッチ及びBlockbuster TOKYO 2019の学び/ Pitch and sharing experience of participating Blockbuster TOKYO 2019 (Dr. Shinya Yuki)
  • 2020年度の活動紹介/ Introduction of programs for Blockbuster TOKYO 2020

日本語・英語の併用/ Mix of Japanese and English

【参加方法/ Enrty】
・製薬・医療領域に関連するスタートアップ、またアカデミック分野にいる方を主な対象としています。/ Audience: early stage startups, academica




Una S. Ryan, O.B.E., Ph.D., D.Sc.
Executive, Entrepreneur, Board Director, Investor, Artist

Dr. Ryan has extensive experience ranging from professor to entrepreneur to private, public and non-profit company CEO to investor to Artist. She has discovered, developed and commercialized diagnostics, therapeutics, medical devices and vaccines. Dr. Ryan currently serves on the boards of Cortexyme (CRTX, Nasdaq) RenovoRx a medical device company, and Elemental Machines, plug-and-play to improve lab functions. She is an LP at Breakout Ventures, Lionheart Ventures and encourages women-led businesse through many roles, including as Managing Director of Golden Seeds, and partner at Astia Angel. Her current portfolio includes approximately 35 start-ups in the Bay Area and Boston. Most interestingly, Her Majesty Queen Elizabeth II awarded Dr. Ryan the Order of the British Empire (OBE).


Shinya Yuki, Ph.D.,
Co-founder, CEO, Elix Inc.

Shinya earned a PhD in physics. After working as a software engineer at DeNA and a Singapore startup, he co-founded Elix in 2016.


Caleb B. Bell III, Ph.D.,
Beyond Next ventures Inc.

Caleb is a passionate entrepreneur, well-published scientist and enthusiastic investor. He received a business training and PhD in Biophysical Chemistry from Stanford University and spun a Cell Therapy company out of Stanford. Through his Academic training and businesses, Caleb has had many interactions with Japan and is focused on building trans Pacific bridges to support commercialization of life science and biotech innovations and innovators.


【Blockbuster TOKYO】
東京都から委託を受けたBeyond Next Ventures(株)が、創薬・医療系ベンチャーやベンチャーの起業を目指す研究者等を対象に実施 する育成支援プログラムです。
Beyond Next Ventures, Inc. operates Tokyo Metropolitan Government's "Blockbuster TOKYO" which is an acceleration program for pharmaceutical and medical startup. The program aims to accelerate foundation and growth of pharmaceutical and medical startups by providing various supports.

【Beyond Next Ventures】
Beyond Next Venturesは、2014年8月に創業した、医療機器、デジタルヘルスや再生医療等のライフサイエンス分野を中心に革新的な技術を有する大学発・技術系ベンチャーへのインキュベーション投資に特化した独立系ベンチャーキャピタルです。
また、2019年からは、日本橋にてシェア型のウェットラボ、「Beyond BioLAB TOKYO」や、技術シーズと共同創業者をマッチングする「Co-founders」を運営しています。
Beyond Next Ventures is a venture capital that supports the creation of startups based on technology from universities. Established in 2014, we invest in innovative start-ups such as life sciences, healthcare, robots, devices, etc. Our program "BRAVE" is the largest accelerating platform in Japan, targeting university areas. And we run "Beyond BioLAB TOKYO", which is the only shared-laboratory in Tokyo.

【Contact information】
Blockbuster TOKYO お問い合わせ先
Blockbuster TOKYO 運営事務局 (Beyond Next Ventures株式会社内)
E-mail : info@blockbuster.tokyo
web : https://www.blockbuster.tokyo

  • イベント詳細情報を更新しました。 Diff#599814 2020-05-27 06:55:44
Thu Jun 4, 2020
12:00 PM - 1:30 PM JST
Add to Calendar
Online event
ライブ中継に参加 FULL
Beyond Next Ventures

[PR] Recommended information